Bapineuzumab: Alzheimer’s Drug Trials Halted (Healthcare Today UK)


Two U.S. drug companies have halted trials of bapineuzumab, an experimental drug to treat Alzheimer’s Disease. The drug failed to produce any improvement in the symptoms of dementia sufferers.

Pfizer Inc. and Johnson & Johnson had been testing bapineuzumab, which had been designed to target brain plaques found in Alzheimer’s patients. Contrary to expectations, the drug failed to improve cognitive or functional ability in patients with the gene ApoE4, which tends to make people who have it more likely to develop the disease.

Read more: Alzheimer’s drug halted after trials. News at Healthcare Today UK.


Alzheimer’s drug halted after trials. Healthcare Today UK, News, August 7th 2012. (Online).

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in For Doctors (mostly), For Researchers (mostly), In the News, International, Pharmacological Treatments, Quick Insights, Universal Interest and tagged , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.